null - FindTrial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2011-003634-14-ES

Enrollment

Registered

2012-01-11

Start date

2012-02-17

Completion date

Unknown

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.1 Level: LLT Classification code 10020419 Term: House dust mite allergy System Organ Class: 10021428 - Immune system disorders

Interventions

Product Name: Extracto alergénico de Blomia tropicalis Product Code: 185 Pharmaceutical Form: Cutaneous solution INN or Proposed INN: Extracto alergénico de Blomia tropicalis Concentration unit: mg/ml

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 30 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Spain

Contacts

Public ContactÁrea de Investigación Clínica

Laboratorios Leti, S.L.Unipersonal

mjgomez@leti.com0034607285953

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026